Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Dyne Therapeutics, Inc. (DYN) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Dyne Therapeutics, Inc. (DYN) - free report >>
Image: Shutterstock
Best Momentum Stocks to Buy for July 18th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 18th:
HF Sinclair (DINO - Free Report) : This energy company which produces and markets light products such as gasoline, diesel fuel, jet fuel, renewable diesel, and other specialty products, has a Zacks Rank #1(Strong Buy) and witnessed the Zacks Consensus Estimate for its current yearearnings increasing 48.1% over the last 60 days.
HF Sinclair Corporation Price and Consensus
HF Sinclair Corporation price-consensus-chart | HF Sinclair Corporation Quote
HF Sinclair’s shares gained 20.2% over the last six months compared with the S&P 500’s decline of 14.3%. The company possesses a Momentum Score of A.
HF Sinclair Corporation Price
HF Sinclair Corporation price | HF Sinclair Corporation Quote
Dyne Therapeutics (DYN - Free Report) :This company which is focused on advanced innovative life-transforming therapeutics for patients with genetically driven diseases, it has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.5% over the last 60 days.
Dyne Therapeutics, Inc. Price and Consensus
Dyne Therapeutics, Inc. price-consensus-chart | Dyne Therapeutics, Inc. Quote
Dyne Therapeutics’s shares gained 32.3% over the last six months compared with the S&P 500’s decline of 14.3%. The company possesses a Momentum Score of A
Dyne Therapeutics, Inc. Price
Dyne Therapeutics, Inc. price | Dyne Therapeutics, Inc. Quote
Dynagas LNG Partners (DLNG - Free Report) : This Glyfada, Greece-based company which is focused on owning and operating LNG carriers that are employed on multi-year contracts with international energy companies, has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.3% over the last 60 days.
Dynagas LNG Partners LP Price and Consensus
Dynagas LNG Partners LP price-consensus-chart | Dynagas LNG Partners LP Quote
Dynagas LNG Partners’ shares gained 7.7% over the last six months compared with the S&P 500’s decline of 14.3%. The company possesses a Momentum Score of B.
Dynagas LNG Partners LP Price
Dynagas LNG Partners LP price | Dynagas LNG Partners LP Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.